Watanabe, T., and H. Onda. 2001. Henoch-Schonlein purpura with antiphospholipid antibodies following an influenza vaccination. Pediatric Nephrology 16(5):458-459.

Wattiaux, M. J., L. Moulonguet-Doleris, J. Cabane, J. Lebas, and J. C. Imbert. 1988. Rheumatoid purpura following influenza vaccination [in French]. Presse Medicale 17(13):649-650.

Wells, C. E. C. 1971. A neurological note on vaccination against influenza. British Medical Journal 3(5777):755-756.

Wharton, C. F., and R. Pietroni. 1974. Letter: Polyarteritis after influenza vaccination. British Medical Journal 2(5914):331-332.

WHO (World Health Organization). 2010. Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season. http://www.who.int/csr/disease/influenza/recommendations_2011_12north/en/index.html (accessed April 9, 2011).

Wiesik-Szewczyk, E., M. Romanowska, P. Mielnik, H. Chwalinska-Sadowska, L. B. Brydak, M. Olesinska, and J. Zabek. 2010. Anti-influenza vaccination in systemic lupus erythematosus patients: An analysis of specific humoral response and vaccination safety. Clinical Rheumatology 29(6):605-613.

Williams, G. W., A. D. Steinberg, J. L. Reinertsen, L. W. Klassen, J. L. Decker, and R. Dolin. 1978. Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Annals of Internal Medicine 88(6):729-734.

Willison, H. J. 2005. The immunobiology of Guillain-Barré syndromes. Journal of the Peripheral Nervous System 10(2):94-112.

Woods, C. A., and G. W. Ellison. 1964. Encephalopathy following influenza immunization. Journal of Pediatrics 65:745-748.

Wright, P. F., S. H. Sell, J. Thompson, and D. T. Karzon. 1976. Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants. Journal of Pediatrics 88(1):31-35.

Wu, Z., H. Wu, and Q. Wang. 1999. A case-control study on Guillain-Barré syndrome in children of north China [in Chinese]. Zhonghua Yufang Yixue Zazhi 33(5):279-281.

Xu, X. Y., S. E. Lindstrom, M. W. Shaw, C. B. Smith, H. E. Hall, B. A. Mungall, K. Subbarao, N. J. Cox, and A. Klimov. 2004. Reassortment and evolution of current human influenza A and B viruses. Virus Research 103(1-2):55-60.

Yahr, M. D., and J. Lobo-Antunes. 1972. Relapsing encephalomyelitis following use of influenza vaccine. Archives of Neurology 27(2):182-183.

Yanai-Berar, N., O. Ben-Itzhak, J. Green, and F. Nakhoul. 2002. Influenza vaccination induced leukocytoclastic vasculitis and pauci-immune crescentic glomerulonephritis. Clinical Nephrology 58(3):220-223.

Yiu, E. M., and A. J. Kornberg. 2010. Acute disseminated encephalomyelitis: Determinants and manifestations. In Inflammatory diseases of the central nervous system, edited by T. Kilpatrick, R. M. Ransohoff, and S. Wesselingh. New York, NY: Cambridge University Press.

Yoo, W. H. 2010. Adult onset Still’s disease following influenza vaccination. Joint Bone Spine 77(4):373-374.

Yuen, K. Y., P. K. S. Chan, M. Peiris, D. N. C. Tsang, T. L. Que, K. F. Shortridge, P. T. Cheung, W. K. To, R. Sung, and A. F. B. Cheng. 1998. Clinical features and rapid viral diagnosis of huma disease associated with avian influenza h5n1 virus. The Lancet 351:467-471.

Zhang, J., G. Li, X. Liu, Z. Wang, W. Liu, and X. Ye. 2009. Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA. Journal of General Virology 90(Pt 11):2751-2758.

Zheng, W., and S. C. Dreskin. 2007. Thimerosal in influenza vaccine: An immediate hypersensitivity reaction. Annals of Allergy, Asthma and Immunology 99(6):574-575.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement